Wolverine Trading, LLC Astrazeneca PLC Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $866,371 - $990,106	11,300 Added 30.54%	48,300 $3.76 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $541,161 - $654,723	-8,100 Reduced 17.96%	37,000 $2.89 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $54,927 - $62,612	900 Added 2.04%	45,100 $3.06 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $7.22 Million - $8.08 Million	-116,700 Reduced 72.53%	44,200 $2.98 Million
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $2.84 Million - $3.14 Million	43,800 Added 37.4%	160,900 $10.9 Million
Q2 2023 Aug 23, 2023	BUY	$69.91 - $75.81 $1.75 Million - $1.9 Million	25,000 Added 27.14%	117,100 $8.38 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $334,695 - $379,479	-5,300 Reduced 5.44%	92,100 $6.37 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $753,519 - $979,116	13,900 Added 16.65%	97,400 $6.6 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.33 Million - $3.41 Million	25,100 Added 42.98%	83,500 $4.59 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.45 Million - $1.74 Million	-24,500 Reduced 29.55%	58,400 $3.91 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $4.62 Million - $5.56 Million	82,900 New	82,900 $5.56 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $7.24 Million - $8.56 Million	-134,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $7.45 Million - $8.15 Million	134,100 New	134,100 $8 Million
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $4.31 Million - $5.36 Million	-89,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $707,400 - $816,600	-15,000 Reduced 14.41%	89,100 $4.45 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $596,796 - $713,646	12,300 Added 13.4%	104,100 $5.22 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1.75 Million - $2.01 Million	32,900 Added 55.86%	91,800 $5.06 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $543,060 - $696,906	-12,600 Reduced 17.62%	58,900 $3.12 Million
Q1 2020 May 11, 2020	BUY	$37.79 - $51.33 $1.2 Million - $1.63 Million	31,800 Added 80.1%	71,500 $3.18 Million
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $101,904 - $121,104	2,400 Added 6.43%	39,700 $1.99 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $2.59 Million - $2.94 Million	-64,600 Reduced 63.4%	37,300 $1.69 Million
Q2 2019 Aug 20, 2019	BUY	$37.28 - $41.68 $3.8 Million - $4.25 Million	101,900 New	101,900 $4.21 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $1.43 Million - $1.73 Million	-40,300 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $143,754 - $161,811	-3,900 Reduced 8.82%	40,300 $1.52 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $736,912 - $842,064	-21,200 Reduced 32.42%	44,200 $1.75 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $2.16 Million - $2.4 Million	65,400 New	65,400 $2.29 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $2.16 Million - $2.34 Million	-67,200 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $1.95 Million - $2.28 Million	67,200	67,200 $2.28 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.17 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.78 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.47 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.44 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.27 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account